Canadian International Pharma Corp. (“CIPC”) is an emerging multi-faceted pharmaceutical company that is in the process of developing generic and nutraceutical drug manufacturing, distribution and sales. CIPC has recently entered into a letter of intent to license the formulations of 99 nutraceutical and pharmaceutical medications. Upon completion of a definitive agreement, and any regulatory approvals, the Company intends to pursue commercial agreements to produce and sell these medications. CIPC has also recently launched its PharmaCert Program. PharmaCert is a certification program for testing and measuring finished dosage forms of nutraceutical and pharmaceutical medications. The Company has also aligned itself with Canadian and US manufacturers with the objective of manufacturing generics and nutraceuticals for Canadian and overseas markets.